BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
BIOMAKERS has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
BIOMAKERS's investors include Oncology Ventures, Endurance28, Sonen Capital, Acumen LatAm Impact Ventures, LabCorp Venture Fund.
BIOMAKERS is headquartered in Recoleta, Argentina.
BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
BIOMAKERS is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BIOMAKERS — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/biomakers. Accessed September 14, 2026.
VCBacked. (2026). BIOMAKERS — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/biomakers
{{cite web |title=BIOMAKERS — Funding & Investors |url=https://www.vcbacked.co/company/biomakers |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated